http://www.renalandurologynews.com Latest articles from Renal and Urology News RUN Home Global news, clinical reviews and expert reports on the latest research and clinical findings in urology and nephrology. Home web@haymarketmedia.com no Pulmonary hypertension is common in hemodialysis (HD) patients and it is associated with an increased death risk, a study found. http://www.renalandurologynews.com/pulmonary-hypertension-common-in-hemodialysis-patients/article/226970/ Fri, 10 Feb 2012 13:00:00 GMT Pulmonary hypertension is common in hemodialysis (HD) patients and it is associated with an increased death risk, a study found. RUN Living kidney donors are at no higher risk for requiring acute dialysis than non-donors, according to a study conducted in Canada and the United States. http://www.renalandurologynews.com/kidney-donors-not-at-higher-risk-of-needing-acute-dialysis/article/226964/ Thu, 09 Feb 2012 13:00:00 GMT Living kidney donors are at no higher risk for requiring acute dialysis than non-donors, according to a study conducted in Canada and the United States. RUN SAN FRANCISCO—Everolimus is the first potential pharmacologic treatment option for patients with angiomyolipoma (AML), a benign tumor that usually occurs in the kidney, researchers reported at the 2012 Genitourinary Cancers Symposium. http://www.renalandurologynews.com/first-possible-drug-therapy-for-angiomyolipoma-reported/article/227036/ Thu, 09 Feb 2012 10:09:05 GMT SAN FRANCISCO—Everolimus is the first potential pharmacologic treatment option for patients with angiomyolipoma (AML), a benign tumor that usually occurs in the kidney, researchers reported at the 2012 Genitourinary Cancers Symposium. RUN SAN FRANCISCO—An immunotherapy (AGS-003) in combination with sunitinib may help prolong the lives of men with unfavorable risk, metastatic renal cell carcinoma (mRCC), according to new data from an open-label phase 2 study. http://www.renalandurologynews.com/immunotherapy-may-improve-mrcc-outcomes/article/226848/ Wed, 08 Feb 2012 14:19:44 GMT SAN FRANCISCO—An immunotherapy (AGS-003) in combination with sunitinib may help prolong the lives of men with unfavorable risk, metastatic renal cell carcinoma (mRCC), according to new data from an open-label phase 2 study. RUN SAN FRANCISCO—Combining a bisphosphonate with sunitinib may improve progression-free survival (PFS) and overall survival (OS) in patients with bone metastases from renal cell carcinoma (RCC), that are treated with sunitinib, according to a multicenter, retrospective study presented at the 2012 Genitourinary Cancer Symposium. http://www.renalandurologynews.com/bisphosphonates-may-improve-outcomes-in-patients-with-rcc-and-bone-metastases/article/226847/ Wed, 08 Feb 2012 14:17:24 GMT SAN FRANCISCO—Combining a bisphosphonate with sunitinib may improve progression-free survival (PFS) and overall survival (OS) in patients with bone metastases from renal cell carcinoma (RCC), that are treated with sunitinib, according to a multicenter, retrospective study presented at the 2012 Genitourinary Cancer Symposium. RUN SAN FRANCISCO—Prior sunitinib treatment for nine months or longer may be associated with a longer progression-free survival (PFS) in patients with metastatic renal cell carcinoma (RCC) receiving axitinib as second-line treatment, according to a new study presented at the 2012 Genitourinary Cancer Symposium. http://www.renalandurologynews.com/prior-sunitinib-duration-affects-second-line-rcc-therapy-outcomes/article/226747/ Tue, 07 Feb 2012 20:32:07 GMT SAN FRANCISCO—Prior sunitinib treatment for nine months or longer may be associated with a longer progression-free survival (PFS) in patients with metastatic renal cell carcinoma (RCC) receiving axitinib as second-line treatment, according to a new study presented at the 2012 Genitourinary Cancer Symposium. RUN Positive change in fitness or fatness impacts cholesterol, hypertension, metabolic syndrome http://www.renalandurologynews.com/change-in-fitness-or-fatness-impacts-cardio-risk-factors/article/226508/ Tue, 07 Feb 2012 00:00:00 GMT Positive change in fitness or fatness impacts cholesterol, hypertension, metabolic syndrome RUN SAN FRANCISCO—The presence of circulating tumor cells (CTC) in the peripheral blood of patients with urothelial carcinoma of the bladder (UCB) prior to radical cystecomy are associated with worse disease outcomes, researchers reported here at the annual Genitourinary Cancers Symposium. http://www.renalandurologynews.com/circulating-tumor-cells-predict-worse-outcomes-in-bladder-cancer-patients/article/226302/ Sat, 04 Feb 2012 18:00:00 GMT SAN FRANCISCO—The presence of circulating tumor cells (CTC) in the peripheral blood of patients with urothelial carcinoma of the bladder (UCB) prior to radical cystecomy are associated with worse disease outcomes, researchers reported here at the annual Genitourinary Cancers Symposium. RUN SAN FRANCISCO—Researchers who compared open and robotic cystectomy for bladder cancer found no significant difference in key outcomes after a median three years of follow-up, according to study findings presented here at the annual Genitourinary Cancers Symposium. http://www.renalandurologynews.com/similar-outcomes-found-with-open-robotic-cystectomy/article/226300/ Sat, 04 Feb 2012 16:00:00 GMT SAN FRANCISCO—Researchers who compared open and robotic cystectomy for bladder cancer found no significant difference in key outcomes after a median three years of follow-up, according to study findings presented here at the annual Genitourinary Cancers Symposium. RUN SAN FRANCISCO—Prostate cancer patients who have never been married are more likely than married men to die from their disease following radical prostatectomy (RP), according to study findings presented here at the annual Genitourinary Cancers Symposium. http://www.renalandurologynews.com/never-married-men-fare-worse-after-prostate-cancer-surgery/article/226299/ Sat, 04 Feb 2012 11:59:47 GMT SAN FRANCISCO—Prostate cancer patients who have never been married are more likely than married men to die from their disease following radical prostatectomy (RP), according to study findings presented here at the annual Genitourinary Cancers Symposium. RUN http://www.renalandurologynews.com/let-patients-sleep-during-rounds/article/225626/ Mon, 01 Jan 0001 05:00:00 GMT RUN http://www.renalandurologynews.com/proton-therapy-safe-effective-for-prostate-cancer/article/225136/ Mon, 01 Jan 0001 05:00:00 GMT RUN http://www.renalandurologynews.com/very-low-testosterone-hikes-prostate-cancer-recurrence-risk/article/226298/ Mon, 01 Jan 0001 05:00:00 GMT RUN http://www.renalandurologynews.com/exercise-enhances-body-composition-nutritional-status-in-dialysis-patients/article/225638/ Mon, 01 Jan 0001 05:00:00 GMT RUN http://www.renalandurologynews.com/remote-care-how-to-use-telemedicine/article/227054/ Mon, 01 Jan 0001 05:00:00 GMT RUN